1. Home
  2. WULF vs KRYS Comparison

WULF vs KRYS Comparison

Compare WULF & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

HOLD

Current Price

$13.48

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$288.37

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WULF
KRYS
Founded
1952
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.3B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
WULF
KRYS
Price
$13.48
$288.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
10
Target Price
$17.58
$250.50
AVG Volume (30 Days)
20.1M
291.8K
Earning Date
02-27-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
N/A
6.66
Revenue
$167,604,000.00
$373,164,000.00
Revenue This Year
$29.95
$36.14
Revenue Next Year
$117.84
$42.38
P/E Ratio
N/A
$43.40
Revenue Growth
30.58
54.51
52 Week Low
$2.06
$122.80
52 Week High
$17.05
$295.98

Technical Indicators

Market Signals
Indicator
WULF
KRYS
Relative Strength Index (RSI) 52.82 67.40
Support Level $12.31 $271.52
Resistance Level $14.55 $295.98
Average True Range (ATR) 0.93 12.27
MACD 0.04 1.05
Stochastic Oscillator 57.84 83.20

Price Performance

Historical Comparison
WULF
KRYS

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: